Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Fine-tuning the electronic structure of heavy-atom-free BODIPY photosensitizers for fluorescence imaging and mitochondria-targeted photodynamic therapy
Ist Teil von
Chemical science (Cambridge), 2020-03, Vol.11 (25), p.6479-6484
Ort / Verlag
England: Royal Society of Chemistry
Erscheinungsjahr
2020
Link zum Volltext
Quelle
EZB Electronic Journals Library
Beschreibungen/Notizen
Theranostics that combines both diagnosis and therapy into a single platform has recently emerged as a promising biomedical approach for cancer treatment; however, the development of efficient theranostic agents with excellent optical properties remains a challenge. Here, we report novel mitochondria-targeting
photosensitizers (
s) that possess considerable singlet oxygen generation capabilities and good fluorescence properties for imaging-guided photodynamic therapy (PDT). The incorporation of sulfur atoms into the π-conjugated skeleton of
along with the introduction of different functional groups at the
-position of the
core is essential for tuning the photophysical and photosensitizing properties. Notably, the MeOPh-substituted thiophene-fused
(
, R =
-methoxyphenyl) displayed the highest singlet oxygen generation capability (
≈ 0.85 in air-saturated acetonitrile) and a moderate fluorescence quantum yield (
= 17.11). Furthermore,
showed good biocompatibility, low dark toxicity and superior fluorescence imaging properties in living cells. More importantly, the PDT efficacy of mitochondria-specific anchoring of
was remarkably amplified with an extremely low half-maximal inhibitory concentration (IC
) value of 95 nM. We believe that the incorporation of an electron-donating group at the
-position of the thiophene-fused
platform may be an effective approach for developing theranostic agents for precision cancer therapy.